Melanoma
Conference Coverage
Vulvar melanoma is increasing in older women
Survival is markedly worse after age 60, when the nodular subtype prevails.
Article
Can an app guide cancer treatment decisions during the pandemic?
News
Biologics may carry melanoma risk for patients with immune-mediated inflammatory diseases
“We advocate for more large, well-designed studies of this issue to be performed to help improve certainty,” the researchers said.
Article
‘A good and peaceful death’: Cancer hospice during the pandemic
Conference Coverage
Germline testing in advanced cancer can lead to targeted treatment
In a study of nearly 12,000 cancer patients, 7%-9% of patients had targetable germline alterations.
News
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
News
Cancer screening, monitoring down during pandemic
Use of some tests came to “a near standstill” in early April.
News
Excess cancer deaths predicted as care is disrupted by COVID-19
Article
ASCO panel outlines cancer care challenges during COVID-19 pandemic
Article
Will coronavirus restrictions lead to more advanced cancers?